More...Snapshot
Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.
The global Deferasirox market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry envir
Table of Content
1 Industry Overview
1.1 Deferasirox Industry
1.1.1 Overview
1.1.2 Development of Deferasirox
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Deferasirox Market by Type
3.1 Segment Overview
3.1.1 500 mg/Tablet